December 2023

Make a New Year's Resolution to Help Those with Gout Stay on a Good Treatment Plan

Hello Gout Education,


The Gout Education Society is committed to raising awareness of gout—the most common form of inflammatory arthritis. The Society arms healthcare professionals, like you, with resources to share with patients and staff—and provides you with access to the most up-to-date research and information about gout and treatment options through GoutEducation.org.


With the holidays underway and New Year's right around the corner, the Society is focused on helping medical professionals make the resolution to continue helping those in need get their uric acid level to below 6.0 mg/dL. With gout on the rise, it's more important than ever for those who treat the disease to ensure their patients are getting the care they need—all year round. This year, the Society implores you to make a New Year's resolution to be part of the solution.


Curious about where to start? The Society has put together the below list of ways to not only educate yourself and those with the disease, but how to reach those in the need as well.


Medical Professional Resources:


Education can help those with gout better understand the disease and debunk common misbeliefs about treatment options. It's also important for those who treat gout to stay up-to-speed on the latest gout management guidelines, research and resources available.


The Society offers several medical professional focused materials for you to arm yourself and staff members with the latest and greatest information:



There are also resources for those who have gout. Below are a few resources to share with patients and their caregivers.



Help Those in Need Find You:


To help those in need find the care they need, the Society has developed the Gout Specialists Network. More information is below to help you sign up for free.


To order other educational materials, visit the Contact Us page on the Society's website.


Have any questions or need resources? Email us: [email protected].

Featured Cartoon




Help your patients ring in the New Year, flare free. Make sure they're getting their uric acid levels checked every six months to achieve a healthy 6.0 mg/dL or below!

Visit Our Cartoon Library

New Blog: Demystifying Gout: Not Just About Foods

By: Gary Ho, Gout Support Group of America

Recently, Gary Ho, who has been managed his gout for more than 20 years, wrote a blog post on myths surrounding the disease and tips for those suffering.


Read more about his approach in our latest blog post.


Co-founder of the Gout Support Group of America, Gary spent more than 15 years dealing with the disease before taking charge of the disease. Founded in 2015, the Gout Support Group of America seeks to help those looking to manage the disease find helpful information and provide a platform to interact with the community.

Read Gary's blog

Help Patients Find Gout Treatment Faster!

Are you a part of our Gout Specialists Network (GSN)?


Joining is easy:


  1. To sign up, visit GoutSpecialistsNetwork.org.
  2. After you register free of charge, update your profile page with information about yourself and your practice.
  3. Enjoy ongoing access to the latest gout information, research and continuing education.


As a member, you can choose to make your practice and professional information available to patients through a medical professional locatorhelping those with gout find qualified medical professionals in their area.

Clinical Trial Seeks People with Hyperuricemia


Tigulixostat, a xanthine oxidase inhibitor, will be studied in a clinical trial. LG Chem is looking for participants from several different regions.


The Phase 3 clinical trial intends to test the drug’s effectiveness for twelve months in people with hyperuricemia versus those who are given a placebo.


Find out who is eligible and how patients can sign up on clinicaltrials.gov

Clinical Trial Seeks People with an Acute Gout Attack


Olatec Therapeutics is seeking participants for its Phase 2/3 clinical trial in patients with an acute gout flare. The objective of the clinical trial is to test an oral anti-inflammatory, called dapansutrile, which is an investigational drug not yet approved by FDA. The trial will assess the effectiveness of dapansutrile in treating inflammatory pain over 8 days in people with gout who are experiencing an acute gout attack versus those who are given a placebo. Rescue treatment is offered if pain remains intolerable while on study. 


The trial is seeking participants located throughout the USA and in Europe. 


To find out who is eligible and how patients can sign up please visit clinicaltrials.gov and/or contact [email protected] 


Clinical Trial Seeks People Around Houston


Advanced Rheumatology of Houston is seeking participants with diagnosed gout for research on treatment options for the disease. Participants must be willing to commit time for study visits at the practice's clinic in The Woodlands, Texas.


To find out who is eligible and how patients can sign up please contact Advanced Rheumatology of Houston at (936) 681 4882

Gout in the News

Stay up to date on the most recent gout news

Healio

'Gout may not be managed properly': Premature mortality in gout remains elevated in US, UK


HCP Live

Treating gout flares with opioid therapy links to chronic opioid use

Urate-lowering therapy could also lower blood pressure in gout patients


HCP Live

Gout flares: Associations with initiation, escalation of urate-lowering therapy


DocWire News

Changes in lipidome of hyperuricemic and gout patients has significant effect on lipid metabolism

Visit GoutEducation.org
Facebook  Twitter  Youtube